Avg 1-year target
10 of 12 long-term calls BUY₹2,576.4434.1% above today's price
Lupin's average 1-year share price target is ₹2,576.44, the average of 9 advisors' latest targets. Targets range from ₹1,400 to ₹3,000.
Latest: HSBC Securities ₹2,500 · 22 Sept 2026
16
14 BUY · 2 SELL, all horizons
9
with an active 1Y target
41%
20 of 49 closed calls hit
66
all horizons, open and closed
Watch LUPIN for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
Lupin target price by brokerage
Each advisor's latest 1-year target · 9 advisors · tap a row for the call
- HSHSBC Securities22 Sept 2026 · via CNBC Awaaz.₹2,500+30.1%
- CCitigroupLow27 Aug 2026 · SELL call · via Zee Business Stocks₹1,400-27.2%
- JIJefferies India27 Aug 2026 · via ET Now (Live)₹2,400+24.9%
- BBernstein27 Aug 2026 · via CNBC Awaaz.₹2,707+40.8%
- NINomura India Research10 Aug 2026 · via CNBC Awaaz.₹2,675+39.2%
- DKDharmesh Kant, Cholamandalam SecuritiesHigh3 Jul 2026 · via CNBC Awaaz.₹3,000+56.1%
All tips (66)
HSbyHSBC Securities+30.1% to target
1 Year* · 11 mo left · 22 Sept 2026 · entry ₹2,123.6 · via CNBC Awaaz.P&L -9.5%
CbyCitigroup+27.2% to target
1 Year* · 10 mo left · 27 Aug 2026 · entry ₹2,166.7 · via Zee Business StocksP&L +11.3%
JIbyJefferies India+24.9% to target
1 Year* · 10 mo left · 27 Aug 2026 · entry ₹2,169.6 · via ET Now (Live)P&L -11.4%
BbyBernstein+40.8% to target
1 Year* · 10 mo left · 27 Aug 2026 · entry ₹2,169.6 · via CNBC Awaaz.P&L -11.4%
CbyCitigroup+22.0% to target
1 Year* · 10 mo left · 24 Aug 2026 · entry ₹2,188 · via Zee Business StocksP&L +12.2%
HSbyHSBC Securities+44.1% to target
1 Year* · 10 mo left · 10 Aug 2026 · entry ₹2,360 · via CNBC Awaaz.P&L -18.6%
NIbyNomura India Research+39.2% to target
1 Year* · 10 mo left · 10 Aug 2026 · entry ₹2,360 · via CNBC Awaaz.P&L -18.6%
DKbyDharmesh Kant, Cholamandalam Securities+56.1% to target
1 Year · 8 mo left · 3 Jul 2026 · entry ₹2,476 · via CNBC Awaaz.P&L -22.4%
PHbyPradeep Haldar, PHD Capital+56.1% to target
1 Year* · 8 mo left · 19 Jun 2026 · entry ₹2,250 · via Business TodayP&L -14.6%
GFbyGeojit Financial Services+35.6% to target
1 Year* · 8 mo left · 4 Jun 2026 · entry ₹2,249.8 · via Institutional / Brokerage ResearchP&L -14.6%
BCbyBOB Capital Markets+50.9% to target
1 Year* · 7 mo left · 10 May 2026 · entry ₹2,379.5 · via Institutional / Brokerage ResearchP&L -19.2%
BCbyBOB Capital Markets+32.8% to target
1 Year* · 4 mo left · 15 Feb 2026 · entry ₹2,199.3 · via Institutional / Brokerage ResearchP&L -12.6%
ISbyICICI SecuritiesTarget hit
1 Year* · 9 Aug 2026 · entry ₹2,360 · via Institutional / Brokerage Researchexit ₹2,200
ASbyAxis SecuritiesTarget hit
1 Year* · 16 Feb 2026 · entry ₹2,221.5 · via Institutional / Brokerage Researchexit ₹2,460
GFbyGeojit Financial ServicesTarget hit
1 Year* · 25 Nov 2025 · entry ₹2,042.3 · via Institutional / Brokerage Researchexit ₹2,225
DCbyDeven Choksey, DRChokseyTarget hit
1 Year* · 13 Nov 2025 · entry ₹2,033.9 · via Institutional / Brokerage Researchexit ₹2,404
ISbyICICI SecuritiesTarget hit
1 Year* · 11 Nov 2025 · entry ₹1,975.9 · via Institutional / Brokerage Researchexit ₹2,275
SRbySharekhan ResearchTarget hit
1 Year* · 21 Aug 2025 · entry ₹1,962.5 · via Institutional / Brokerage Researchexit ₹2,400
EGbyEmkay GlobalTarget hit
1 Year* · 7 Aug 2025 · entry ₹1,944.2 · via Institutional / Brokerage Researchexit ₹2,500
PLbyPrabhudas LilladherTarget hit
1 Year* · 16 May 2025 · entry ₹2,068.4 · via Institutional / Brokerage Researchexit ₹2,400
ASbyAxis SecuritiesTarget hit
1 Year* · 8 Aug 2024 · entry ₹2,050.8 · via Institutional / Brokerage Researchexit ₹2,200
SRbySharekhan ResearchTarget hit
1 Year* · 7 Aug 2024 · entry ₹1,994.45 · via Institutional / Brokerage Researchexit ₹2,400
ASbyAxis SecuritiesTarget hit
1 Year* · 8 May 2024 · entry ₹1,616.15 · via Institutional / Brokerage Researchexit ₹1,800
SRbySharekhan ResearchTarget hit
1 Year* · 15 Apr 2024 · entry ₹1,611.45 · via Institutional / Brokerage Researchexit ₹1,868
SSbySBI SecuritiesTarget hit
1 Year* · 13 Feb 2024 · entry ₹1,608.75 · via Institutional / Brokerage Researchexit ₹1,838
ASbyAxis SecuritiesTarget hit
1 Year* · 9 Feb 2024 · entry ₹1,622.1 · via Institutional / Brokerage Researchexit ₹1,770
RBbyRajesh Bhosale, Angel OneStop-loss hit
1 Year · 26 Aug 2026 · entry ₹2,180.6 · via NDTV Profitexit ₹2,100
PHbyPradeep Haldar, PHD CapitalStop-loss hit
1 Year · 31 Jul 2026 · entry ₹2,417.9 · via Business Todayexit ₹2,050
DKbyDharmesh Kant, Cholamandalam SecuritiesStop-loss hit
1 Year · 3 Jul 2026 · entry ₹2,473 · via CNBC Awaaz.exit ₹2,470
ASbyAxis SecuritiesExpired
1 Year* · 13 Feb 2025 · entry ₹2,055.25 · via Institutional / Brokerage Researchexit ₹2,199.3
BCbyBOB Capital MarketsExpired
1 Year* · 13 Feb 2025 · entry ₹2,055.25 · via Institutional / Brokerage Researchexit ₹2,199.3
PLbyPrabhudas LilladherExpired
1 Year* · 13 Feb 2025 · entry ₹2,055.25 · via Institutional / Brokerage Researchexit ₹2,199.3
ASbyAxis SecuritiesExpired
1 Year* · 11 Nov 2024 · entry ₹2,084.9 · via Institutional / Brokerage Researchexit ₹1,975.9
EGbyEmkay GlobalExpired
1 Year* · 10 Nov 2024 · entry ₹2,104.6 · via Institutional / Brokerage Researchexit ₹1,990.2
BCbyBOB Capital MarketsExpired
1 Year* · 9 Nov 2024 · entry ₹2,104.6 · via Institutional / Brokerage Researchexit ₹1,971.8
ISbyICICI SecuritiesExpired
1 Year* · 10 Jul 2024 · entry ₹1,826.9 · via Institutional / Brokerage Researchexit ₹1,894.8
AJbyAnand James, Geojit Investments+27.0% to target
1–3 Months* · 2 mo left · 22 Sept 2026 · entry ₹2,200 · via Business Standard MarketsP&L -12.6%
AAbyAditya Agarwal, Coheron Brokers+19.7% to target
1–3 Months* · 2 mo left · 21 Sept 2026 · entry ₹2,117.6 · via Business TodayP&L -9.2%
ABbyAmbareesh Baliga+24.9% to target
1–3 Months* · 5 wk left · 28 Aug 2026 · entry ₹2,171.5 · via ET Now (Live)P&L -11.5%
SMbySomil Mehta, SharekhanTarget hit
1–3 Months · 18 Jun 2026 · entry ₹2,326.9 · via CNBC Awaaz.exit ₹2,430
RSbyRahul Sharma, JM FinancialTarget hit
1–3 Months · 4 May 2026 · entry ₹2,348.8 · via CNBC Awaaz.exit ₹2,500
SMbySomil Mehta, SharekhanTarget hit
1–3 Months* · 10 Apr 2026 · entry ₹2,333.8 · via CNBC Awaaz.exit ₹2,400
JSbyJigar S Patel, Anand RathiStop-loss hit
1–3 Months · 28 Sept 2026 · entry ₹2,060.9 · via ET Nowexit ₹2,000
SMbySomil Mehta, SharekhanStop-loss hit
1–3 Months · 21 Sept 2026 · entry ₹2,119.1 · via CNBC Awaaz.exit ₹2,070
MKbyMehul Kothari, Anand RathiStop-loss hit
1–3 Months* · 21 Sept 2026 · entry ₹2,109 · via Zee Business (Live)exit ₹2,000
AMbyAjit Mishra, ReligareExpired
1–3 Months* · 6 Apr 2026 · entry ₹2,400 · via NDTV Profitexit ₹2,491.6
AAbyAditya Agarwal, Coheron Brokers+9.3% to target
1–2 Weeks* · 13d left · 22 Oct 2026 · entry ₹1,937.4 · via Business TodayP&L -0.8%
RPbyRajesh Palviya, Axis SecuritiesStop-loss hit
1–2 Weeks* · 17 Aug 2026 · entry ₹2,259 · via CNBC Awaaz.exit ₹2,230
* Horizon not stated by the source; assumed from how far the target is from the entry price.
Full call history, all horizons: page 2 of 2
Compare Pharmaceuticals & Biotechnology targets
Most-covered stocks in the sector · average 1-year target
- DRREDDYDr. Reddy's Laboratories Limited₹1,346+8.6% · 19 calls
- CIPLACipla Ltd.₹1,524+14.5% · 17 calls
- SUNPHARMASun Pharmaceutical Industries Ltd.₹2,226+26.6% · 15 calls
- BIOCONBiocon Ltd₹485+46.9% · 12 calls
- LUPIN· this stockLupin Limited₹2,576+34.1% · 12 calls
- AUROPHARMAAurobindo Pharma₹1,622+0.7% · 11 calls

